Sage Therapeutics and Biogen BIIB Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression Met its Primary and All Key Secondary Endpoints 。$Sage Therapeutics(SAGE)$ $Biogen制药(BIIB)$

GABA-A受体别构调控剂国内也有企业布局prodrug。